Sebia CAPILLARYS 3 TERA is now connected to Inpeco FlexLab automation.
Sebia is pleased to release the new edition HbA1c Meta-Analysis.
The Sebia Minicap Flex Piercing system utilises the proven, high performance technology of capillary electrophoresis for clear separation of analytes.
The Sebia HbA1c kit is designed for the separation and quantitation of the HbA1c glycosylated fraction of haemoglobin in human blood by capillary electrophoresis providing a high throughput method with clear-cut and precise results.
New Publication: A Novel Approach to Estimating M-Protein Concentration: Capillary Electrophoresis Quantitative Immunosubtraction
Abacus dx and Sebia are pleased to advise you of a new publication:
Title: A Novel Approach to Estimating M-Protein Concentration: Capillary Electrophoresis Quantitative Immunosubtraction
Latest information on the new Capillarys 3 Automation solutions from Sebia.
Abacus dx as the exclusive Australian distributor of Sebia, is pleased to announce the availability of the HYDRASHIFT 2/4 DARATUMUMAB assay, intended to be used with HYDRAGEL IF, for the qualitative detection of monoclonal proteins in human serum by immunofixation electrophoresis.
The Sebia Capillarys2 Flex Piercing system utilises the proven, high performance technology of capillary electrophoresis for clear separation of analytes. It features whole blood analysis, with no pre-analytical preparation; cap-piercing for improved workflow. It is a fully automated, innovative multi-parameter system. There are more than 6,000 systems installed worldwide.
Sebia are world leaders in Electrophoresis testing. Their capillary electrophoresis [CE] technology leads the market with systems to suit both small and large laboratories; along with a large test menu.